Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from KDA Group Inc. ( (TSE:KDA) ) is now available.
KDA Group Inc. has announced the expansion of its Medherize platform to community pharmacies, marking a significant advancement in the management of oral anticancer therapies. This deployment integrates pharmacists into the digital ecosystem for monitoring oral therapies, enhancing the continuity of care and adherence to treatment plans. The platform aligns with Quebec’s new framework for oral anticancer medications, providing pharmacists with real-time access to patient data and enabling proactive intervention. This development positions Medherize as a central tool in the modern process of dispensing and monitoring oral anticancer treatments, strengthening the role of pharmacies in patient care.
More about KDA Group Inc.
KDA Group Inc. is a leader in technological innovations and specialized software solutions for healthcare professionals. The company offers high-quality products and has recognized expertise in the pharmaceutical and medical sectors, aiming to accelerate healthcare’s digital transformation for Canadian and international markets.
Average Trading Volume: 75,067
Technical Sentiment Signal: Buy
Current Market Cap: C$51.53M
See more data about KDA stock on TipRanks’ Stock Analysis page.